Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Diseases × Bone Density × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Breast Neoplasms 2 Wilms Tumor 1 Sarcoma, Ewing 1 Ovarian Neoplasms 1 Osteosarcoma 1 Osteoporosis 1 Neuroblastoma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hepatoblastoma 1 Endometrial Neoplasms 1 Desmoid Tumors 1 Cystic Fibrosis 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Diseases 1 Breast Carcinoma In Situ 1

Interventions

palbociclib 5 Trastuzumab 5 Fulvestrant 5 Docetaxel 5 Anastrozole 5 exemestane 4 Letrozole 4 ribociclib 3 pyrotinib 3 entinostat 3 abemaciclib 3 Cyclophosphamide 3 Sodium Chloride 2 Paclitaxel 2 Lapatinib 2 Exercise 2 Everolimus 2 Capecitabine 2 Botulinum Toxins, Type A 2 tucatinib 1 sacubitril and valsartan sodium hydrate drug combination 1 pertuzumab 1 pembrolizumab 1 pegfilgrastim 1 ipatasertib 1 gadoterate meglumine 1 figitumumab 1 elacestrant 1 dactolisib 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00842465 2013-11-25

Prolacsein

Assistance Publique - Hôpitaux de Paris

Breast Diseases, Breast Neoplasms, Cystic Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡